Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$2,909.0B | 7.0 | $431.5 10.3% undervalued | (8.2%) | $261.8B | $70.0B | 15.0% | 26.7% | 69.4% | 27.5% | 20.6% | |
$916.5B | 8.4 | $332.6 88.2% undervalued | 27.7% | NT$2,894.3B | NT$894.9B | 33.9% | 30.9% | 56.1% | 29.1% | 22.8% | |
$479.1B | 6.0 | $641.9 24.2% undervalued | 6.8% | $396.6B | $20.7B | 7.9% | 5.2% | 21.6% | 17.9% | 75.0% | |
$438.2B | 6.5 | $182.5 19.9% undervalued | 19.3% | $55.8B | $5,812.0M | 6.2% | 10.4% | 69.8% | 15.5% | 557.8% | |
$393.8B | 6.0 | $196.9 20.3% undervalued | 8.4% | $88.8B | $18.1B | 4.3% | 20.3% | 69.1% | 15.7% | 51.2% | |
$370.7B | 6.0 | $301.2 43.4% undervalued | 22.6% | $56.3B | $17.8B | 3.7% | 31.7% | 73.6% | 8.3% | 1,996.0% | |
$317.5B | 6.3 | $277.1 1.7% undervalued | 41.2% | €34.2B | €4,423.0M | 9.5% | 12.9% | 73.0% | 9.0% | 23.3% | |
$269.1B | 7.4 | $283.1 0.9% undervalued | (8.6%) | $37.9B | $12.4B | 8.7% | 32.8% | 77.2% | 9.4% | 18.6% | |
$240.1B | 6.3 | $72.5 20.2% undervalued | 24.7% | $54.2B | $13.2B | (5.3%) | 24.4% | 64.8% | 12.7% | 68.2% | |
$236.6B | 7.5 | $112.8 21.1% undervalued | (23.1%) | $64.2B | $18.1B | 6.7% | 28.2% | 80.8% | 26.5% | 80.0% | |
$235.4B | 7.1 | $167.3 10.5% undervalued | 70.2% | $37.8B | $10.8B | 7.5% | 28.5% | 64.2% | 21.7% | (463.0%) | |
$222.8B | 6.6 | $151.0 34.7% undervalued | 16.7% | $51.1B | $13.8B | 0.1% | 27.0% | 74.7% | 17.7% | 70.8% | |
$219.7B | 6.1 | $112.9 59.0% undervalued | 10.6% | $284.3B | $35.1B | (10.2%) | 12.3% | 19.0% | 13.8% | 42.8% | |
$218.8B | 7.1 | $187.7 48.6% undervalued | 15.6% | $42.0B | $6,351.0M | 4.6% | 15.1% | 55.6% | 25.3% | 31.4% | |
$199.7B | 6.1 | $149.1 2.5% undervalued | (12.9%) | $91.9B | $7,189.0M | 0.4% | 7.8% | 54.6% | 17.3% | 247.4% | |
$197.8B | 6.4 | $634.6 22.6% undervalued | (11.2%) | $42.9B | $7,267.0M | 0.1% | 16.9% | 41.5% | 7.9% | 63.0% | |
$174.1B | 7.5 | $270.0 72.2% undervalued | (6.4%) | $40.7B | $12.7B | 12.1% | 31.3% | 56.0% | 42.4% | 54.2% | |
$170.8B | 5.9 | $449.4 42.2% undervalued | 17.6% | $33.4B | $10.4B | 18.6% | 31.1% | 61.5% | 11.9% | 1,022.6% | |
$169.1B | 6.8 | $608.7 0.8% undervalued | (6.7%) | $17.2B | $5,632.0M | 13.7% | 32.8% | 78.9% | 13.3% | 39.3% | |
$153.2B | 6.9 | $28.6 13.4% undervalued | 43.0% | ¥13.8T | ¥3,176.9B | 9.6% | 23.0% | 26.6% | 14.9% | 51.4% |
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover the Magnificent 7 stocks—market leaders with stellar performance. Learn what they are and track their latest metrics.
Review premium stocks that beat benchmarks this week, offering consistent returns and stability.